iPharmaCenter

Putting patients at center

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Home

  • COVID-19

  • News

  • Conferences

  • Healthcare Policies & Systems

  • Regional News

    • North America
    • Europe
    • APAC
  • Patient info

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • TraditionalHealthcare
    • Healthcare Systems
    • News
    • Conferences
    • Know your disease
    • COVID
    • Japan drug approvals
    • USA Pharma News | Healthcare News
    • Europe Pharma News
    • Japan drug approvals
    • Australia Pharma & Healthcare News
    • Canada Pharma and Healthcare News
    • Asia | Pharma | Healthcare News
    • Indication News
    Search
    CMS News | HHS | USA | Medicare, and Medicaid | Health insurance | Healthcare News
    ipharmaservices
    • 17 minutes ago

    CMS News | HHS | USA | Medicare, and Medicaid | Health insurance | Healthcare News

    0
    2022 FDA Drug Approvals
    ipharmaservices
    • 2 days ago

    2022 FDA Drug Approvals

    0
    COVID19 drug updates | FDA EMA approved COVID19 drugs
    ipharmaservices
    • Jan 18

    COVID19 drug updates | FDA EMA approved COVID19 drugs

    0
    FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK
    ipharmaservices
    • Dec 23, 2021

    FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

    0
    ~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio
    ipharmaservices
    • Dec 23, 2021

    ~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio

    0
    Myasthenia Gravis News | FDA and EMA approvals |
    ipharmaservices
    • Dec 22, 2021

    Myasthenia Gravis News | FDA and EMA approvals |

    0
    American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
    ipharmaservices
    • Nov 10, 2021

    American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates

    0
    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
    ipharmaservices
    • Nov 3, 2021

    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

    0
    FDA approved Novartis Scembli for chronic myeloid leukemia
    ipharmaservices
    • Nov 2, 2021

    FDA approved Novartis Scembli for chronic myeloid leukemia

    0
    Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
    ipharmaservices
    • Jun 8, 2021

    Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval

    0
    CMS News | US Healthcare News | Medicare and Medicaid News |
    ipharmaservices
    • May 11, 2021

    CMS News | US Healthcare News | Medicare and Medicaid News |

    0
    GSK’s Jemperli received approval in Europe and the US for endometrial cancer
    ipharmaservices
    • Apr 23, 2021

    GSK’s Jemperli received approval in Europe and the US for endometrial cancer

    0
    Gilead’s Trodelvy approved for triple-negative breast cancer in US
    ipharmaservices
    • Apr 9, 2021

    Gilead’s Trodelvy approved for triple-negative breast cancer in US

    0
    ipharmaservices
    • Mar 28, 2021

    BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma

    0
    FDA to review the accelerated approvals of Keytruda, Opdivo, and Tecentriq
    ipharmaservices
    • Mar 13, 2021

    FDA to review the accelerated approvals of Keytruda, Opdivo, and Tecentriq

    0
    ipharmaservices
    • Feb 21, 2021

    Novartis’ blockbuster Entresto received the US FDA approval for a broader target population

    0
    US FDA approved BMS gene therapy Breyanzi
    ipharmaservices
    • Feb 8, 2021

    US FDA approved BMS gene therapy Breyanzi

    0
    ipharmaservices
    • Jan 20, 2021

    Merck and Bayer announced the US FDA approval for Verquvo

    0
    Expected best selling pharmaceutical products (drugs) in 2021
    ipharmaservices
    • Jan 20, 2021

    Expected best selling pharmaceutical products (drugs) in 2021

    0
    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
    ipharmaservices
    • Jan 12, 2021

    Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

    0
    1
    234

    Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

    For any further updates, contact us at ipharmaservices@gmail.com

    ©2022 by ipharmaservices